16:18 IST
NSE
Dividend
GlaxoSmithKline Pharmaceuticals Dividend
GlaxoSmithKline Pharmaceuticals recommended a final dividend of ₹57 per equity share for 2026. The record date is May 29, 2026, pending shareholder approval.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
1 announcement with these filters
GlaxoSmithKline Pharmaceuticals recommended a final dividend of ₹57 per equity share for 2026. The record date is May 29, 2026, pending shareholder approval.